Skip to main content
SpringerLink
Log in

Urinary biochemical markers for bone resorption during the menstrual cycle

  • Clinical Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

In order to analyze the effects of serum ovarian steroid hormones on bone metabolism during the menstrual cycle, we have measured urinary levels of type I collagen cross-linked N-telopeptide (NTx), hydroxylysylpyridinoline (HP), lysylpyridinoline (LP), and hydroxyproline (OH-Pr) in nine healthy Japanese women, aged 22–43 years, with normal ovarian function. The cycles were synchronized by serum LH peaks, and follicular and luteal periods were normalized by lengths. Serum gonadotropins and ovarian sex steroids showed significantly different cyclic variations during the menstrual periods. Urinary NTx remained unchanged during the early follicular period, showed a rise during the mid- and late follicular period, and a fall during the mid- and late luteal periods. There were significant differences in NTx levels between early follicular period and midfollicular period (P<0.01), or late follicular period (P<0.05), and between early luteal period and late luteal period (P<0.05). The levels of HP and LP showed a rise during the early and midfollicular periods and a fall during the midluteal period. The correlation of NTx with urinary OH-Pr was better than with urinary HP or LP (r=0.731 versus r=0.449 or r=0.634). This variation suggests that cyclic changes in serum ovarian sex steroids might modulate bone resorption markers during the menstrual cycle.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. DeMerre LJ, Lotosky FS (1968) Alkaline-phosphatase activity during menstruation. Fertil Steril 19:593–597

    Google Scholar 

  2. Pitkin RM, Reynolds AR, Williams GA, Hargis KG (1978) Calcium-regulating hormones during the menstrual cycle. J Clin Endocrinol Metab 47:626–632

    Google Scholar 

  3. Baran DT, Whyte MP, Haussler MR, Deftos LJ, Slatopolsky E, Avioli LV (1980) Effect of the menstrual cycle on calciumregulating hormones in the normal young woman. J Clin Endocrinol Metab 50:377–379

    Google Scholar 

  4. Gray TK, McAdoo T, Hatley L, Lester GE, Thierry M (1982) Fluctuation of serum concentration of 1,25-dihydroxyvitamin D3 during the menstrual cycle. Am J Obstet Gynecol 144:880–884

    Google Scholar 

  5. Tjellesen L, Christiansen C, Hummer L, Larsen NE (1983) Unchanged biochemical indices of bone turnover despite fluctations in 1,25-dihydroxyvitamin D during the menstrual cycle. Acta Endocrinol (Copenh) 102:476–480

    Google Scholar 

  6. Muse KN, Manolagas SC, Deftos LJ, Alexander N, Yen SSC (1986) Calcium-regulating hormones across the menstrual cycle. J Clin Endocrinol Metab 62:1313–1315

    Google Scholar 

  7. Buchanan JR, Santen RJ, Cavaliere A, Cauffman SW, Greer RB, Demers LM (1986) Interaction between parathyroid hormone and endogenous estrogen in normal women. Metabolism 35:489–494

    Google Scholar 

  8. Nielsen HK, Brixen K, Bouillon R, Mosekilde L (1990) Changes in biochemical markers of osteoblastic activity during the menstrual cycle. J Clin Endocrinol Metab 70:1431–1437

    Google Scholar 

  9. El-Hajj Fuleihan G, Hall JE, Porrino N, Gleason R, Crowley WF Jr (1993) Intact parathyroid hormone levels across the menstrual cycle. J Bone Miner Res 8 (suppl 1):S188

  10. Gorai I, Hosoda K, Chaki O, Minaguchi H (1993) Changes in intact and N-fragment osteocalcin and other biochemical indices during the menstrual cycle. J Bone Miner Res 8 (suppl 1):S290

    Google Scholar 

  11. Singer FR, Schiller AL, Pyle EB, Krane SM (1978) Paget's disease of bone. In: Avioli LV, Krane SM (eds) Metabolic bone disease, vol II. Academic Press, New York, p 489

    Google Scholar 

  12. Deacon AC, Hulme P, Hesp R, Green JR, Tellez M, Reeve J (1987) Estimation of whole body bone resorption rate: a comparison of urinary total hydroxyproline excretion with two radioisotopic tracer methods in osteoporosis. Clin Chem Acta 166:297–306

    Google Scholar 

  13. Weiss PH, Klein L (1969) The quantitative relationship of urinary peptide hydroxyproline excretion to collagen degradation. J Clin Invest 48:1

    Google Scholar 

  14. Kivirikko KI (1970) Urinary excretion of hydroxyproline in health and disease. Int Rev Connect Tissue Res 5:93–163

    Google Scholar 

  15. Gunja-Smith Z, Boucek RJ (1981) Collagen cross-linking compounds in human urine. Biochem J 197:759–762

    Google Scholar 

  16. Fujimoto D, Suzuki M, Uchiyama A, Miyamoto S, Inoue T (1983) Analyses of pyridinoline, a cross-linking compound of collagen fibers, in human urine. J Biochem 94:1133–1136

    Google Scholar 

  17. Black D, Duncan A, Robins SP (1989) Quantitative analysis of the pyridinium crosslinks of collagen in urine using ionpaired reversed-phase high-performance liquid chromatography. Anal Biochem 169:197–203

    Google Scholar 

  18. Uebelhart D, Gineyts E, Chapuy MC, Delmas PD (1990) Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Miner 8:87–96

    Google Scholar 

  19. Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD (1991) Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab 72:367–373

    Google Scholar 

  20. Colwell A, Eastell R, Assiri AMA, Russell RGG (1990) Effect of diet on deoxypyridinoline excretion. In: Christiansen C, Overgaard K (eds) Osteoporosis 1990, vol 2. Osteopress Aps, Copenhagen, p 520

    Google Scholar 

  21. Beardsworth LJ, Eyre DR, Dickson IR (1990) Changes with age in the urinary excretion of lysyl-and hydroxylysylpyridinoline: two new markers of bone collagen turnover. J Bone Miner Res 5:671–676

    Google Scholar 

  22. Hanson DA, Weis MAE, Bollen AM, Maslan SL, Singer FR, Eyre DR (1992) A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 11:1251–1258

    Google Scholar 

  23. Komm BS, Terpening CH, Benz DJ, Graeme KA, Gallegos A, Kore M, Greene GL, O'Malley BW, Haussler MR (1988) Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 241:81–84

    Google Scholar 

  24. Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL (1988) Evidence of estrogen receptors in normal osteoblast cells. Science 241:84–86

    Google Scholar 

  25. Pensler JM, Radosevich JA, Higbee R, Langman CB (1990) Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors. J Bone Miner Res 5:797–802

    Google Scholar 

  26. Orimo H, Fujita T, Yoshikawa M (1972) Increased sensitivity of bone to parathyroid hormone in ovariectomized rats. Endocrinology 90:760–763

    Google Scholar 

  27. Apone S, Fevold K, Lee M, Eyre DR (1994) A rapid method for quantifying osteoclast activity in vitro. J Bone Miner Res 9 (suppl 1):S178

    Google Scholar 

  28. Schlemmer A, Hassager C, Jensen SB, Christiansen C (1992) Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women. J Clin Endocrinol Metab 74:476–480

    Google Scholar 

  29. Davison JM, Noble MBC (1981) Serial changes in 24-hour creatinine clearance during the normal menstrual cycle and the first trimester of pregnancy. Br J Obstet Gynecol 88:10–17

    Google Scholar 

  30. Paaby P, Möller-Petersen J, Larsen CE, Raffn K (1987) Endogenous overnight creatinine clearance. Serum beta2-microglobulin and serum water during the menstrual cycle. Acta Med Scand 221:191–197

    Google Scholar 

  31. Schlemmer A, Hassager C, Risteli J, Risteli L, Jensen SB, Christiansen C (1993) Possible variation in bone resorption during the normal menstrual cycle. Acta Endocrinol (Copenh) 129: 388–392

    Google Scholar 

  32. Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J (1993) Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation to bone histomorphometry. J Bone Miner Res 8:127–132

    Google Scholar 

  33. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L (1993) Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 39:635–640

    Google Scholar 

  34. Bernard MP, Myers JC, Chu ML, Ramirez F, Eikenberry EF, Rrockop DJ (1983) Structure of a cDNA for the proα2 chain of human type I collagen. Comparison with chick cDNA forα2 (I) identifies structurally conserved features of the protein and the gene. Biochemistry 22:1139–1145

    Google Scholar 

  35. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C (1994) Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 40:2022–2025

    Google Scholar 

  36. Hassager C, Jensen LT, Pødenphant J, Thomsen K, Christiansen C (1994) The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: the effect of nandrolone decanoate and hormone replacement therapy. Calcif Tissue Int 54:30–33

    Google Scholar 

  37. Rosen HN, Dresner-Pollak R, Moses AC, Rosenblatt M, Zeind AJ, Clements JD, Greenspan SL (1994) Specificity of urinary excretion of cross-linked N-telopeptides of Type I collagen as a marker of bone turnover. Calcif Tissue Int 54:26–29

    Google Scholar 

  38. Gertz BJ, Shao P, Hanson DA, Quan H, Harris ST, Genant HK, Chesnut CH, Eyre DR (1994) Monitoring bone resorption in early postmenopausal women by an immunoassay for crosslinked collagen peptides in urine. J Bone Miner Res 9:135–141

    Google Scholar 

  39. Johansen JS, Jensen SB, Riis BJ, Christiansen C (1990) Time-dependent variations in bone turnover parameters during 2 months' cyclic treatment with different doses of combined estrogen and progestogen in postmenopausal women. Metabolism 39:1122–1126

    Google Scholar 

  40. Prestwood KM, Pilbeam CC, Burleson JA, Woodiel FN, Delmas PD, Deftos LJ, Raisz LG (1994) The short-term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab 79:366–371

    Google Scholar 

  41. Seyedin SM, Kung VT, Daniloff YN, Hesley RP, Gomez B, Nielsen LA, Rosen HN, Zuk RF (1993) Immunoassay for urinary pyridinoline: the new marker of bone resorption. J Bone Miner Res 8:635–641

    Google Scholar 

  42. Delmas PD, Gyneyts E, Bertholin A, Garnero P, Marchand F (1993) Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease. J Bone Miner Res 8:643–648

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, 236, Yokohama, Japan

    I. Gorai, O. Chaki, M. Nakayama & H. Minaguchi

Authors
  1. I. Gorai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. Chaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Nakayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Minaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gorai, I., Chaki, O., Nakayama, M. et al. Urinary biochemical markers for bone resorption during the menstrual cycle. Calcif Tissue Int 57, 100–104 (1995). https://doi.org/10.1007/BF00298428

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00298428

Key words

Search

Navigation